tiprankstipranks
Vertex Pharmaceuticals (DE:VX1)
XETRA:VX1
Germany Market

Vertex Pharmaceuticals (VX1) Technical Analysis

23 Followers

Summary of all the Indicators

Overall Consensus
Sell
5Bullish
3Neutral
14Bearish
Technical Analysis Consensus
Buy
5Bullish
3Neutral
2Bearish
Moving Average Consensus
Strong Sell
0Bullish
0Neutral
12Bearish
Vertex Pharmaceuticals’s (VX1) Moving Averages Convergence Divergence (MACD) indicator is -7.54, suggesting Vertex Pharmaceuticals is a Buy.
Vertex Pharmaceuticals’s (VX1) 20-Day exponential moving average is 385.04, while Vertex Pharmaceuticals’s (VX1) share price is €372.8, making it a Sell.
Vertex Pharmaceuticals’s (VX1) 50-Day exponential moving average is 391.60, while Vertex Pharmaceuticals’s (VX1) share price is €372.8, making it a Sell.

Vertex Pharmaceuticals (VX1) Pivot Points

Apr 16, 2026, 09:04 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
364.98
368.52
371.33
374.87
377.68
381.22
384.03
Fibonacci
368.52
370.94
372.44
374.87
377.29
378.79
381.22
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Vertex Pharmaceuticals (VX1) Moving Averages

Apr 16, 2026, 09:04 AM
Period
Simple
Exponential
MA5
375.01Sell
375.24Sell
MA10
378.50Sell
378.65Sell
MA20
386.24Sell
385.04Sell
MA50
397.58Sell
391.60Sell
MA100
392.05Sell
389.58Sell
MA200
375.49Sell
384.34Sell
Vertex Pharmaceuticals’s (VX1) 10-Day exponential moving average is 378.65, while Vertex Pharmaceuticals’s (VX1) share price is €372.8, making it a Sell.
Vertex Pharmaceuticals’s (VX1) 100-Day exponential moving average is 389.58, while Vertex Pharmaceuticals’s (VX1) share price is €372.8, making it a Sell.
Vertex Pharmaceuticals’s (VX1) stock price is €372.8 and Vertex Pharmaceuticals’s (VX1) 50-day simple moving average is 397.58, creating a Sell signal.
Vertex Pharmaceuticals’s (VX1) stock price is €372.8 and Vertex Pharmaceuticals’s (VX1) 100-day simple moving average is 392.05, creating a Sell signal.
Vertex Pharmaceuticals’s (VX1) stock price is €372.8 and Vertex Pharmaceuticals’s (VX1) 200-day simple moving average is 375.49, creating a Sell signal.

Vertex Pharmaceuticals (VX1) Technical Indicators

Apr 16, 2026, 09:04 AM
Name
Value
Implied Action
RSI (14)
39.65
Neutral
STOCH (9,6)
23.50
Neutral
STOCHRSI (14)
18.17
Buy
MACD (12,26)
-7.54
Buy
ADX (14)
12.37
Buy
Williams %R
-79.68
Buy
CCI (14)
-106.99
Buy
ATR (14)
7.33
-
Ultimate Oscillator
31.91
Neutral
ROC
-4.80
Sell
Vertex Pharmaceuticals’s (VX1) Relative Strength Index (RSI) is 39.65, creating a Neutral signal.
Vertex Pharmaceuticals’s (VX1) Trend Strength Indicator (ADX) is 12.37, creating a Buy signal.
Vertex Pharmaceuticals’s (VX1) Commodity Channel Index (CCI) is -106.99, creating a Buy signal.
Vertex Pharmaceuticals’s (VX1) Price Rate of Change (ROC) is -4.80, creating a Sell signal.

FAQ

Is VX1 a Buy, Hold, or Sell?
Based on VX1’s technical indicators, VX1 is a Sell.
    What is VX1’s RSI (14)?
    VX1’s RSI (14) is 39.65, which suggests VX1 is a Neutral.
      What is VX1’s MACD?
      VX1’s MACD is -7.54, which suggests VX1 is a Buy.
        What is VX1’s 5-day moving average?
        VX1’s 5-day moving average is 375.01, which suggests VX1 is a Sell.
          What is VX1’s 20-day moving average?
          VX1 20-day moving average is 386.24, which suggests VX1 is a Sell.
            What is VX1’s 50-day moving average?
            VX1’s 50-day moving average is 397.58, which suggests VX1 is a Sell.
              What is VX1’s 200-day moving average?
              VX1’s 200-day moving average is 375.49, which suggests VX1 is a Sell.
                What is VX1’s Williams % R (14)?
                VX1’s Williams % R (14) is -79.68, which suggests VX1 is a Buy.
                  What is VX1’s CCI (14)?
                  VX1’s CCI (14) is -106.99, which suggests VX1 is a Buy.
                    What is the share price of Vertex Pharmaceuticals?